Skip to main content

The Effect of Bimatoprost Implant on Glaucoma Patients: An Observational Study.

Publication ,  Journal Article
Choi, EY; Johnson, NA; Stinnett, S; Rosdahl, J; Moya, F; Herndon, LW
Published in: J Glaucoma
June 1, 2024

PRCIS: In this retrospective study of glaucoma patients receiving the bimatoprost implant at Duke Eye Center, the number of topical intraocular pressure-lowering medications was significantly reduced through 12 months after the implant. PURPOSE: To study the effects of the bimatoprost implant on intraocular pressure (IOP) and the need for topical IOP-lowering medications in glaucoma patients in the clinical practice setting. PATIENTS AND METHODS: Patients who received the bimatoprost implant at Duke Eye Center from November 2020 to October 2021 were identified. Exclusion criteria included addition of other IOP-lowering medications concurrent with the implant and <1 month of follow-up. The change in IOP and number of topical IOP-lowering medications from baseline to months 1, 3, 6, 9, and 12 after the implant was calculated. Subgroup analysis was performed for different glaucoma severities. RESULTS: A total of 63 patients and 92 eyes were included (mean age 77.8 ± 10.1 years). Glaucoma severity ranged from mild (11%), moderate (30%), to severe (54%). There was a nonsignificant decrease in IOP at all timepoints. The mean number of topical IOP-lowering medications significantly decreased by 0.81, 0.75, 0.63, 0.70, and 0.67 at month 1, 3, 6, 9, and 12, respectively (all P < 0.001). There was no significant change in the total number of medications, including the bimatoprost implant. When divided by glaucoma severity, the reduction in the number of topical medications was significant at 1, 3, and 6 months for mild/moderate disease and at 1 month for severe disease. During the follow-up period, 19 eyes underwent additional laser or surgical procedures, 68% of which had a history of prior incisional glaucoma surgery. CONCLUSIONS: The bimatoprost implant may reduce the need for topical IOP-lowering agents over a 1-year period, especially in mild to moderate-stage glaucoma. The efficacy of the implant may be more limited in severe glaucoma, and further work is needed to characterize its long-term effects.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Glaucoma

DOI

EISSN

1536-481X

Publication Date

June 1, 2024

Volume

33

Issue

6

Start / End Page

431 / 436

Location

United States

Related Subject Headings

  • Tonometry, Ocular
  • Retrospective Studies
  • Ophthalmology & Optometry
  • Middle Aged
  • Male
  • Intraocular Pressure
  • Humans
  • Glaucoma
  • Follow-Up Studies
  • Female
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Choi, E. Y., Johnson, N. A., Stinnett, S., Rosdahl, J., Moya, F., & Herndon, L. W. (2024). The Effect of Bimatoprost Implant on Glaucoma Patients: An Observational Study. J Glaucoma, 33(6), 431–436. https://doi.org/10.1097/IJG.0000000000002368
Choi, Eun Young, Nicholas A. Johnson, Sandra Stinnett, Jullia Rosdahl, Frank Moya, and Leon W. Herndon. “The Effect of Bimatoprost Implant on Glaucoma Patients: An Observational Study.J Glaucoma 33, no. 6 (June 1, 2024): 431–36. https://doi.org/10.1097/IJG.0000000000002368.
Choi EY, Johnson NA, Stinnett S, Rosdahl J, Moya F, Herndon LW. The Effect of Bimatoprost Implant on Glaucoma Patients: An Observational Study. J Glaucoma. 2024 Jun 1;33(6):431–6.
Choi, Eun Young, et al. “The Effect of Bimatoprost Implant on Glaucoma Patients: An Observational Study.J Glaucoma, vol. 33, no. 6, June 2024, pp. 431–36. Pubmed, doi:10.1097/IJG.0000000000002368.
Choi EY, Johnson NA, Stinnett S, Rosdahl J, Moya F, Herndon LW. The Effect of Bimatoprost Implant on Glaucoma Patients: An Observational Study. J Glaucoma. 2024 Jun 1;33(6):431–436.

Published In

J Glaucoma

DOI

EISSN

1536-481X

Publication Date

June 1, 2024

Volume

33

Issue

6

Start / End Page

431 / 436

Location

United States

Related Subject Headings

  • Tonometry, Ocular
  • Retrospective Studies
  • Ophthalmology & Optometry
  • Middle Aged
  • Male
  • Intraocular Pressure
  • Humans
  • Glaucoma
  • Follow-Up Studies
  • Female